Document is current

Article History

Received: 6 October 2023

Accepted: 29 February 2024

First Online: 11 March 2024

Declarations

:

: This study is a retrospective analysis of anonymized data. Therefore, due to German law, ethical approval is not necessary.

: All patients provided written informed consent for device implantation and data acquisition.

: Martin Beyer received travel compensation from Abbott. Sebastian Ludwig received travel compensation from Edwards Lifesciences Inc. Hermann Reichenspurner received travel compensation and lecture remunerations from Edwards Lifesciences Inc. and Medtronic Inc. Lenard Conradi serves on the advisory board for Medtronic, Abbott, and JenaValve and is consultant for Edwards Lifesciences, Boston Scientific, MicroPort, PiCardia, Neovasc, and MicroInterventions. Moritz Seifert reports personal fees and non-financial support from Abbott Vascular; personal fees from Abiomed; personal fees from AstraZeneca; personal fees from Bayer Healthcare; personal fees from Boehringer Ingelheim; grants, personal fees, and non-financial support from Boston Scientific; personal fees from Bristol-Myers Squibb; personal fees and non-financial support from Edwards Lifesciences; grants and personal fees from Philips; personal fees from Medtronic; personal fees from Amgen; personal fees from Shockwave Medical; personal fees from Daiichi Sankyo; personal fees from Pfizer; personal fees from Siemens Healthineers; and personal fees from Inari Medical. Andreas Schäfer received travel compensation from Edwards Lifesciences Inc. and lecture fees from Abbott and Boston Scientific. All other authors declared no conflict of interest.